Cargando…

MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection

Methyl-CpG binding domain 2 (MBD2) leads to the silencing of methylated genes in cancer cells and was implicated in the activation of prometastatic genes in hepatocellular carcinoma (HCC). The present study aimed to investigate the expression status of MBD2 in HCC and the correlation with surgical o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Wang, Na, Lu, Min, Du, Xiao-Juan, Xing, Bao-Cai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940051/ https://www.ncbi.nlm.nih.gov/pubmed/27315121 http://dx.doi.org/10.3892/mmr.2016.5404

Ejemplares similares

Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma
por: Liu, Wei, et al.
Publicado: (2016)

MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma
por: Li, Liantao, et al.
Publicado: (2020)

Sarcopenia and visceral adiposity predict poor overall survival in hepatocellular carcinoma patients after curative hepatic resection
por: Jang, Hee Yoon, et al.
Publicado: (2021)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2012)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

MBD2 and MBD3: elusive functions and mechanisms
por: Menafra, Roberta, et al.
Publicado: (2014)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Controversies and evidence of hepatic resection for hepatocellular carcinoma()
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection
por: Hyeon, Jiyeon, et al.
Publicado: (2013)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Preoperative prealbumin-to-fibrinogen ratio to predict survival outcomes in hepatocellular carcinoma patients after hepatic resection
por: Yan, Haixi, et al.
Publicado: (2022)

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
por: Zhaohui, Zhang, et al.
Publicado: (2019)

Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2021)

MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2
por: Yan, Weiwei, et al.
Publicado: (2022)

Serum Prealbumin is Negatively Associated with Survival in Hepatocellular Carcinoma Patients after Hepatic Resection
por: Liao, Ying-Yang, et al.
Publicado: (2019)

Hepatic resection for hepatocellular carcinoma in the octogenarian: is it justified?
por: Lee, Chao-Wei, et al.
Publicado: (2019)

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2013)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection
por: Lee, Chao-Wei, et al.
Publicado: (2013)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection
por: Li, Fang, et al.
Publicado: (2018)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
por: Ji, Fei, et al.
Publicado: (2018)

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival
por: Yu, SiZhe, et al.
Publicado: (2020)

Long-term survival after resection of hepatocellular carcinoma
por: Kim, Ki Hoon, et al.
Publicado: (2012)

INFLUENCE OF HEPATOCELLULAR CARCINOMA ETIOLOGY IN THE SURVIVAL AFTER RESECTION
por: LOPES, Felipe de Lucena Moreira, et al.
Publicado: (2016)

The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA
por: Laget, Sophie, et al.
Publicado: (2010)

DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells
por: Hainer, Sarah J, et al.
Publicado: (2016)

SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival
por: Zhang, Xin-yue, et al.
Publicado: (2023)

Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection
por: Li, Guang-Jun, et al.
Publicado: (2017)

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
por: Lee, Jung Min, et al.
Publicado: (2016)

The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma: Erratum
Publicado: (2015)

Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study
por: Chen, Junwei, et al.
Publicado: (2016)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Zheng, Ninggang, et al.
Publicado: (2016)

Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy
por: Feng, Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l3iaiqqe6kd43ld7gbkbrnubb4